1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Jiangsu Aidea Pharmaceutical Co., Ltd.

Jiangsu Aidea Pharmaceutical Co., Ltd.

688488.SS
Jiangsu Aidea Pharmaceutical Co., Ltd.CN flagShanghai Stock Exchange
15.50
CNY
+1.30
- -
6.52BMarket Cap

Total Valuation

Jiangsu Aidea Pharmaceutical Co., Ltd. carries a market capitalization of 6.52B, placing it among publicly traded companies globally. Its enterprise value stands at 5.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.52B
Enterprise Value5.55B

Share Statistics

Jiangsu Aidea Pharmaceutical Co., Ltd. currently has 420.78M shares outstanding.

Shares Outstanding420.78M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 9.00, and the price-to-book ratio stands at 56.60.

PE RatioN/A
PS Ratio9.00
PB Ratio56.60
P/TBV Ratio7.26
P/FCF Ratio191.55
P/OCF RatioN/A

Enterprise Valuation

EV / Sales9.27
EV / EBITDAN/A
EV / EBITN/A
EV / FCF131.83

Financial Position

Jiangsu Aidea Pharmaceutical Co., Ltd. maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 48.98, indicating elevated leverage, while an interest coverage ratio of -1.17 demonstrates limited ability to service its debt obligations.

Current Ratio1.40
Quick Ratio0.69
Debt / Equity48.98
Debt / EBITDA-28.39
Interest Coverage-1.17

Financial Efficiency

Return on Equity (ROE)-62.46
Return on Assets (ROA)-4.82
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)20.19
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.92

Taxes

Over the trailing twelve months, Jiangsu Aidea Pharmaceutical Co., Ltd. has paid -10.28M in income taxes, reflecting an effective tax rate of 31.47.

Income Tax-10.28M
Effective Tax Rate31.47

Stock Price Statistics

Jiangsu Aidea Pharmaceutical Co., Ltd.'s stock has gained approximately 9.46328% over the past 52 weeks. The 50-day moving average sits at 14.87, while the 200-day moving average is 15.73.

Beta (5Y)N/A
52-Week Price Change9.46328%
50-Day Moving Average14.87
200-Day Moving Average15.73
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Jiangsu Aidea Pharmaceutical Co., Ltd. generated 599.22M in revenue and converted that into -86.58M in net income, yielding earnings per share of -0.17. EBITDA reached -18.78M, while operating income came in at -18.78M.

Revenue599.22M
Gross Profit378.97M
Operating Income-18.78M
Pretax Income-77.19M
Net Income-86.58M
EBITDA-18.78M
EBIT-18.78M
Earnings Per Share (EPS)-0.17

Balance Sheet

Jiangsu Aidea Pharmaceutical Co., Ltd. holds 472.90M in cash and equivalents against 533.05M in total debt, resulting in a net debt position of 39.26M. Total book value stands at 95.32M, with working capital of 274.40M providing operational flexibility.

Cash & Cash Equivalents472.90M
Total Debt533.05M
Net Debt39.26M
Equity (Book Value)95.32M
Book Value Per Share0.24
Working Capital274.40M

Cash Flow

After subtracting -28.17M in capital expenditures, free cash flow totaled -28.17M - equivalent to -0.07 per share.

Operating Cash FlowN/A
Capital Expenditures-28.17M
Free Cash Flow-28.17M
FCF Per Share-0.07

Margins

Jiangsu Aidea Pharmaceutical Co., Ltd. operates with a gross margin of 63.24, reflecting its pricing power and cost economics. The operating margin of -3.13 and net profit margin of -14.45 provide insight into operational efficiency.

Gross Margin63.24
Operating Margin-3.13
Pretax Margin-12.88
Profit Margin-14.45
EBITDA Margin-3.13

Dividends & Yields

The company's payout ratio of -45.79 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.05
Dividend YieldN/A
Payout Ratio-45.79
Shareholder Yield-1.95
FCF Yield0.52

Scores

Jiangsu Aidea Pharmaceutical Co., Ltd. posts an Altman Z-Score of 4.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.15